Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01260506 |
| Title | Single-Arm Open-Label Multicenter Study of VB-111 in Patients With Recurrent Glioblastoma Multiforme |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Vascular Biogenics Ltd. operating as VBL Therapeutics |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | ISR |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Dana Farber Cancer Institute | Boston | Massachusetts | United States | Details | ||
| Duke University Medical Center | Durham | North Carolina | United States | Details | ||
| Uthsc- Ctrc | San Antonio | Texas | United States | Details | ||
| Tel Aviv Sourasky Medical Center | Tel Aviv | 64239 | Israel | Details |